President & CEO
Lisa Earnhardt leads Intersect ENT (NASDAQ: XENT), a medical technology company dedicated to improving the quality of life for patients with ear, nose and throat conditions having led the company from the early clinical stage. Previously, she was President of Boston Scientific’s Cardiac Surgery division. Lisa has over two decades of experience in healthcare, primarily in leading global product launches and driving adoption of new medical technologies at both Boston Scientific and Guidant. Lisa began her career at APM/CSC Healthcare where she provided management consulting services to healthcare provider organizations. She received a Bachelor of Science in industrial engineering from Stanford University, and holds an MBA from Northwestern’s Kellogg School of Management. Lisa serves on the boards of Intersect ENT and Nevro Corporation (NYSE: NVRO). Lisa is a member of the Kellogg Global Advisory Board and Young Presidents’ Organization.